Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 9 - Number 4

Immune Cell Entry to Central Nervous System - Current Understanding and Prospective Therapeutic Targets

, 9(4): 315 - 327

Catriona T. Prendergast and Stephen M. Anderton


DOI: 10.2174/187153009789839219




Dendritic Cells for Active Anti-Cancer Immunotherapy: Targeting Activation Pathways Through Genetic Modification

, 9(4): 328 - 343

Karine Breckpot and David Escors


DOI: 10.2174/187153009789839156




MHC Class I TCR Engineered Anti-Tumor CD4 T Cells: Implications For Cancer Immunotherapy

, 9(4): 344 - 352

Arvind Chhabra


DOI: 10.2174/187153009789839183




Interleukin-24: A Molecule with Potential Anti-Cancer Activity and a Cytokine in Search of a Function

, 9(4): 353 - 360

Ali Dalloul and Alexander Sainz-Perez


DOI: 10.2174/187153009789839200




Synergistic Activation of Leukocytes by Bacterial Chemoattractants: Potential Drug Targets

, 9(4): 361 - 370

Ling-Yu Chen and Zhixing K. Pan


DOI: 10.2174/187153009789839165




Future Developments in Osteoporosis Therapy

, 9(4): 371 - 384

K. W. Ng


DOI: 10.2174/187153009789839192




Pleiotropic Effects of Cathepsin D

, 9(4): 385 - 391

Aruna Vashishta, Sujata Saraswat Ohri and Vaclav Vetvicka


DOI: 10.2174/187153009789839174




A Current Update on the Use of Alpha Lipoic Acid in the Management of Type 2 Diabetes Mellitus

, 9(4): 392 - 398

Z. X. Poh and K. P. Goh


DOI: 10.2174/187153009789839147




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science